IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers

BACKGROUND AND AIMS: Monitoring the immune response against SARS-CoV-2 is pivotal in the evaluation of long-term vaccine efficacy. Immunoglobulin G (IgG) antibodies represent an advisable tool to reach this goal, especially for the still poorly defined antibody trend induced by the new class of mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Brisotto, Giulia, Muraro, Elena, Montico, Marcella, Corso, Chiara, Evangelista, Chiara, Casarotto, Mariateresa, Caffau, Cristina, Vettori, Roberto, Cozzi, Maria Rita, Zanussi, Stefania, Turetta, Matteo, Ronchese, Federico, Steffan, Agostino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555109/
https://www.ncbi.nlm.nih.gov/pubmed/34755649
http://dx.doi.org/10.1016/j.cca.2021.10.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555109/
https://www.ncbi.nlm.nih.gov/pubmed/34755649
http://dx.doi.org/10.1016/j.cca.2021.10.035

Ejemplares similares